A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $55 to $92

Futu NewsJan 11 21:00 · Ratings

Express News | Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsJan 11 06:15

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireJan 11 06:15

Crinetics Pharmaceuticals' Atumelnant Trial Data Prompts Hold Rating Amid Efficacy and Safety Concerns

TipRanksJan 11 03:36 · Ratings

Crinetics Shares Fall After Reporting 'Positive' Phase 2 Results for Congenital Adrenal Hyperplasia Treatment

MT NewswiresJan 11 02:19

Strong Buy Rating for Crinetics Pharmaceuticals Driven by Promising Atumelnant Data and Market Potential

TipRanksJan 11 01:25 · Ratings